- Home
- VTSI vs LUNG Comparison
VTSI vs LUNG Comparison
Compare VTSI & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTSI
- LUNG
- Stock Information
- Founded
- VTSI 1993
- LUNG 1995
- Country
- VTSI United States
- LUNG United States
- Employees
- VTSI N/A
- LUNG N/A
- Industry
- VTSI Miscellaneous manufacturing industries
- LUNG Industrial Specialties
- Sector
- VTSI Consumer Discretionary
- LUNG Health Care
- Exchange
- VTSI Nasdaq
- LUNG Nasdaq
- Market Cap
- VTSI 61.9M
- LUNG 65.6M
- IPO Year
- VTSI N/A
- LUNG 2020
- Fundamental
- Price
- VTSI N/A
- LUNG $1.78
- Analyst Decision
- VTSI Strong Buy
- LUNG Buy
- Analyst Count
- VTSI 1
- LUNG 7
- Target Price
- VTSI $7.00
- LUNG $7.66
- AVG Volume (30 Days)
- VTSI 51.8K
- LUNG 322.6K
- Earning Date
- VTSI 11-11-2025
- LUNG 10-29-2025
- Dividend Yield
- VTSI N/A
- LUNG N/A
- EPS Growth
- VTSI N/A
- LUNG N/A
- EPS
- VTSI 0.10
- LUNG N/A
- Revenue
- VTSI $27,068,543.00
- LUNG $90,549,000.00
- Revenue This Year
- VTSI $10.31
- LUNG $10.30
- Revenue Next Year
- VTSI $12.71
- LUNG $14.72
- P/E Ratio
- VTSI $62.35
- LUNG N/A
- Revenue Growth
- VTSI N/A
- LUNG 18.24
- 52 Week Low
- VTSI $3.57
- LUNG $1.47
- 52 Week High
- VTSI $8.53
- LUNG $9.37
- Technical
- Relative Strength Index (RSI)
- VTSI 61.39
- LUNG 49.33
- Support Level
- VTSI $5.19
- LUNG $1.71
- Resistance Level
- VTSI $5.84
- LUNG $1.94
- Average True Range (ATR)
- VTSI 0.26
- LUNG 0.11
- MACD
- VTSI 0.09
- LUNG 0.02
- Stochastic Oscillator
- VTSI 95.00
- LUNG 44.03
About VTSI VirTra Inc.
VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.